The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
The second-generation antipsychotic olanzapine is effective in reducing psychotic symptoms but can cause extreme weight gain in human patients. We investigated the role of the gut microbiota in this adverse drug effect using a mouse model. First, we used germ-free C57BL/6J mice to demonstrate that gut bacteria are necessary and sufficient for weight gain caused by oral delivery of olanzapine. Second, we surveyed fecal microbiota before, during, and after treatment and found that olanzapine potentiated a shift towards an "obesogenic" bacterial profile. Finally, we demonstrated that olanzapine has antimicrobial activity in vitro against resident enteric bacterial strains. These results collectively provide strong evidence for a mechanism underlying olanzapine-induced weight gain in mouse and a hypothesis for clinical translation in human patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Effect of high-fat diet (HFD) and olanzapine (OLZ) treatment on diversity of gut microbiota during crossover study. (A) Within-subject (α) diversity, quantified by Fisher's α [45]; larger values indicate greater diversity (n = 95 samples = 4 time points ×24 subjects – 1 failed sample). Panels are split by study arm (see Error! Reference source not found.) and points are colored according to diet and treatment status: on regular chow prior to initiation of HFD (regular), during treatment with placebo (HFD-placebo) or during treatment with OLZ (HFD-OLZ). Each point represents a single individual and bars indicate 95% confidence intervals about the point estimates; observations on the same subject are connected by a grey line. (B) Between-subjects (β) diversity (n = 95 samples = 4 time points ×24 subjects – 1 failed sample). Pairwise distances between samples were calculated using weighted UniFrac and visualized using non-metric multidimensional scaling along two axes, which together explain 98% of between-subjects variance. Observations on the same subject are connected by a grey line.](https://figures.cochat.ai/paper-figures/a936ae05344f4303a8dbe754682036f6/the-antipsychotic-olanzapine-interacts-with-the-gut-microbiome-to-cause-weight-figure-3.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Olanzapine administration decreased overall microbial diversity, lowered abundance of Bacteroidia, and increased abundances of Erysipelotrichia, Actinobacteria, and Gammaproteobacteria.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [188]
In the citing paper
“a lack of significant increase of the body weight in olanzapine-treated GF mice and a rapid weight gain upon microbial colonization in this study indicate that the olanzapine-induced weight gain was dependent on the presence of gut microbiota [188].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [188]
In the citing paper
“olanzapine, which induces alterations in gut microbiome composition in rodents linked to the weight gain and other metabolic side effects that are associated with its use”
From Gut reactions: Breaking down xenobiotic–microbiome interactions (2019) · cites this paper as Morgan et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · cited 1×
“0 package [38].”
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885 · cited 1×
“OTUs were assigned a taxonomic identity with the RDP classifier [37] trained on the most recent release (4 February 2011) of the Los Alamos National Laboratory’s GreenGenes taxonomic reference (gg_97_otus_4feb2011), using the scripts in the QIIME v1.”
MethodA new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828 · cited 2×
“Between-group differences in overall microbiota composition were assessed by PERMANOVA [42] as implemented in the R package vegan (http://vegan.r-forge.r-project.org), and visualized using nonmetric multidimensional scaling as implemented in the R package MASS [43].”
MethodAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“Recent studies in animal models and humans have demonstrated a causal role for the gut microbiome in obesity [19–24], which is mediated by complex interactions with host environment [25, 26], diet [21, 27] and genetics [25, 28].”
BackgroundA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“Bacterial concentrations can be as high as 10(11) cells/mL in the distal gut, encompassing a gene repertoire 150 times larger than that of the human host [15] with broad-ranging metabolic capacity [16, 17].”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“The specific alterations in gut community composition that we attribute to olanzapine are similar to those attributed to high-fat diet [19, 21, 22, 30, 31].”
BackgroundUniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227 · cited 8×
“In the weighted UniFrac analysis (Fig.”
MethodInfluentialEffectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · cited 1×
“Since their introduction in the 1990s, olanzapine and other atypical antipsychotics have come into widespread clinical use because they are efficacious and usually lack the extrapyramidal adverse drug reactions associated with older, ‘‘typical’’ antipsychotics like haloperidol [1, 2].”
BackgroundFastTree: Computing Large Minimum Evolution Trees with Profiles instead of a Distance Matrix
Price, M. N., Dehal, P. S., & Arkin, A. P. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp077 · Cited by 5,602 · cited 1×
“Consensus sequences for the OTUs were aligned using PyNAST [39] (via QIIME) guided by the aforementioned GreenGenes reference alignment, and a corresponding phylogeny inferred using FastTree [40] (via QIIME).”
Method
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Extensive impact of non-antibiotic drugs on human gut bacteria
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., et al. (2018) · Nature · doi:10.1038/nature25979 · Cited by 1,905
“This raises the possibility that direct bacterial inhibition may not only manifest as side effect for antipsychotics 26, but also be part of their MoA.”
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration
Dinan, T. G., & Cryan, J. F. (2017) · The Journal of Physiology · doi:10.1113/jp273106 · Cited by 813
“Indeed, recent studies from our group (Davey et al. 2012; 2013) and others (Morgan et al. 2014; Bahr et al. 2015) point to a key role of the microbiome in manifesting antipsychotic-induced weight gain.”
BackgroundSystematic Review of Gut Microbiota and Major Depression
Cheung, S. G., Goldenthal, A. R., Uhlemann, A.-C., Mann, J. J., Miller, J. M., & Sublette, M. E. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00034 · Cited by 597
Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection
Ducarmon, Q. R., Zwittink, R. D., Hornung, B. V. H., van Schaik, W., Young, V. B., & Kuijper, E. J. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-19 · Cited by 566
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Sorboni, S. G., Moghaddam, H. S., Jafarzadeh-Esfehani, R., & Soleimanpour, S. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00338-20 · Cited by 522
Microbiota-gut-brain axis: Modulator of host metabolism and appetite
van de Wouw, M., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2017) · The Journal of Nutrition · doi:10.3945/jn.116.240481 · Cited by 461
“Rodents receiving olanzapine also have an altered gut microbiota composition (61, 62).”
BackgroundAnimal models of metabolic syndrome: a review
Wong, S. K., Chin, K.-Y., Suhaimi, F. H., Fairus, A., & Ima-Nirwana, S. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0123-9 · Cited by 371
Gut reactions: Breaking down xenobiotic–microbiome interactions
Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015768 · Cited by 319
“It has also been demonstrated that olanzapine has antimicrobial properties in vitro against two bacterial strains commonly residing in the human gut (Morgan et al., 2014).”
BackgroundMicrobiota regulation of the mammalian gut-brain axis
Burokas, A., Moloney, R. D., Dinan, T. G., & Cryan, J. F. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2015.02.001 · Cited by 300
Kim, Y.-K., & Shin, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170915141036 · Cited by 271
“showed that olanzapine induces subtle changes in the composition of the gut microbiota, beyond the effects of high-fat diet therapy [131].”
BackgroundDifferential effects of psychotropic drugs on microbiome composition and gastrointestinal function
Cussotto, S., Strain, C. R., Fouhy, F., Strain, R. G., Peterson, V. L., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5006-5 · Cited by 266
Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications
Le Bastard, Q., Al‐Ghalith, G. A., Grégoire, M., Chapelet, G., Javaudin, F., Dailly, E., Batard, E., Knights, D., & Montassier, E. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14451 · Cited by 263
Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
Flowers, S. A., Evans, S. J., Ward, K. M., McInnis, M. G., & Ellingrod, V. L. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1890 · Cited by 235
Aging, Frailty, and the Microbiome—How Dysbiosis Influences Human Aging and Disease
Haran, J. P., & McCormick, B. A. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.060 · Cited by 216
Gut Microbiota: The Conductor in the Orchestra of Immune–Neuroendocrine Communication
El Aidy, S., Dinan, T. G., & Cryan, J. F. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.03.002 · Cited by 215
“These findings of a microbiota-dependent, olanzapine-induced weight gain have recently been confirmed in GF mice, and in in vitro studies point to a direct interaction between olanzapine and microbes.(101)”
ResultGut microbiota composition is associated with polypharmacy in elderly hospitalized patients
Ticinesi, A., Milani, C., Lauretani, F., Nouvenne, A., Mancabelli, L., Lugli, G. A., Turroni, F., Duranti, S., Mangifesta, M., Viappiani, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10734-y · Cited by 211
Programming Bugs: Microbiota and the Developmental Origins of Brain Health and Disease
Codagnone, M. G., Spichak, S., O’Mahony, S. M., O’Leary, O. F., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.06.014 · Cited by 198
Bahr, S. M., Tyler, B. C., Wooldridge, N., Butcher, B. D., Burns, T. L., Teesch, L. M., Oltman, C. L., Azcarate-Peril, M. A., Kirby, J. R., & Calarge, C. A. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.135 · Cited by 197
Psychotropics and the Microbiome: a Chamber of Secrets…
Cussotto, S., Clarke, G., Dinan, T. G., & Cryan, J. F. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5185-8 · Cited by 163
High-Diversity Mouse Populations for Complex Traits
Saul, M. C., Philip, V. M., Reinholdt, L. G., & Chesler, E. J. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.04.003 · Cited by 165
“Examples include psychotropic drug response [48,49], infectious disease response [50], and transcript splice variation [51] across the founders.”
BackgroundThe atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C
Lord, C. C., Wyler, S. C., Wan, R., Castorena, C. M., Ahmed, N., Mathew, D., Lee, S., Liu, C., & Elmquist, J. K. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93362 · Cited by 161
“To characterize its metabolic effects, we adopted an olanzapinesupplemented diet to reproduce human plasma olanzapine levels in female C57BL/6 mice (18).”
MethodYuan, X., Zhang, P., Wang, Y., Liu, Y., Li, X., Kumar, B. U., Hei, G., Lv, L., Huang, X.-F., Fan, X., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.05.017 · Cited by 158
The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications
Szeligowski, T., Yun, A. L., Lennox, B. R., & Burnet, P. W. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00156 · Cited by 150
“Some studies identified a decrease in the abundance of Bacteroidetes and increase in Firmicutes [reviewed in (72)], which is interestingly a pattern also reported following olanzapine treatment (as discussed above)—a drug known to induce weightgain.”
InfluentialFecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders
Evrensel, A., & Ceylan, M. E. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.3.231 · Cited by 150
Drug–gut microbiota interactions: implications for neuropharmacology
Walsh, J., Griffin, B. T., Clarke, G., & Hyland, N. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14366 · Cited by 149
“The role of the gut microbiome in the development of olanzapine-induced weight gain was elucidated when olanzapine-treated GF mice did not gain weight but did so upon colonization with caecal microbiota (Morgan et al., 2014).”
BackgroundSkonieczna-Żydecka, K., Marlicz, W., Misera, A., Koulaouzidis, A., & Łoniewski, I. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120521 · Cited by 147
“Lastly, OLZ suppressed the growth of anaerobic bacteria [117] and Escherichia coli NC101 [118].”
BackgroundBahr, S. M., Weidemann, B. J., Castro, A. N., Walsh, J. W., deLeon, O., Burnett, C. M. L., Pearson, N. A., Murry, D. J., Grobe, J. L., & Kirby, J. R. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.10.018 · Cited by 143
Altered gut microbiota associated with symptom severity in schizophrenia
Li, S., Zhuo, M., Huang, X., Huang, Y., Zhou, J., Xiong, D., Li, J., Liu, Y., Pan, Z., Li, H., et al. (2020) · PeerJ · doi:10.7717/peerj.9574 · Cited by 142
Gao, M., Wang, J., Liu, P., Tu, H., Zhang, R., Zhang, Y., Sun, N., & Zhang, K. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02670-5 · Cited by 175
An in vitro model maintaining taxon-specific functional activities of the gut microbiome
Li, L., Abou-Samra, E., Ning, Z., Zhang, X., Mayne, J., Wang, J., Cheng, K., Walker, K., Stintzi, A., & Figeys, D. (2019) · Nature Communications · doi:10.1038/s41467-019-12087-8 · Cited by 133
Ortega, M. A., Álvarez-Mon, M. Á., Montero, C. G., Fraile‐Μartinez, O., Monserrat, J., Martinez-Rozas, L., Rodríguez–Jiménez, R., Álvarez‐Mon, M., & Lahera, G. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01964-w · Cited by 150
“In rats, olanzapine modi fi es gut microbiota to an obesogenic bacterial pro fi le (similarly to the alterations observed in humans), so that gut microbiota is suf fi cient and essential to induce this weight gain [250].”
BackgroundKao, A. C.-C., Spitzer, S., Anthony, D. C., Lennox, B., & Burnet, P. W. J. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0116-8 · Cited by 128
Gut microbes in neurocognitive and mental health disorders
Halverson, T., & Alagiakrishnan, K. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1808239 · Cited by 125
“This is absent in germ-free mice Morgan et al. 2014 [155] If treated with a probiotic (B-GOS) the weight gain caused by olanzapine is attenuated in female rats Kao et al. 2018 [156] Human Alteration of Lachnospiraceae, Akkermansia, and Sutterella between controls and patients treated with atypical…”
BackgroundInfluentialBicknell, B. T., Liebert, A. D., Borody, T. J., Herkes, G., McLachlan, C. S., & Kiat, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119577 · Cited by 147
“Olanzapine induces weight gain, causes metabolic disturbances, and alters the gut microbiome [193].”
The gut microbiome and mental health: advances in research and emerging priorities
Shoubridge, A. P., Choo, J. M., Martin, A. M., Keating, D. J., Wong, M., Licinio, J., & Rogers, G. B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01479-w · Cited by 144
Cattane, N., Richetto, J., & Cattaneo, A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.001 · Cited by 117
The role of the gut microbiome in the development of schizophrenia
Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.02.010 · Cited by 110
Skonieczna-Żydecka, K., Łoniewski, I., Misera, A., Stachowska, E., Maciejewska, D., Marlicz, W., & Galling, B. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5102-6 · Cited by 98
“Morgan et al. (2014) confirmed the relationship between weight gain and OLZ administration using the cross-over model, proving that the relative abundance of bacteria of the Erysipelotrichi class was related to weight gain.”
BackgroundMethodResultInfluentialThe Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
Libowitz, M. R., & Nurmi, E. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.623681 · Cited by 99
“In fact, AIWG is absent in germ-free mice but can be induced by microbiome transplant (251).”
BackgroundThe effects of antipsychotic medications on microbiome and weight gain in children and adolescents
Bretler, T., Weisberg, H., Koren, O., & Neuman, H. (2019) · BMC Medicine · doi:10.1186/s12916-019-1346-1 · Cited by 105
Inflammatory Markers in Anorexia Nervosa: An Exploratory Study
Dalton, B., Campbell, I. C., Chung, R., Breen, G., Schmidt, U., & Himmerich, H. (2018) · Nutrients · doi:10.3390/nu10111573 · Cited by 95
The connection between microbiome and schizophrenia
Golofast, B., & Vales, K. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.011 · Cited by 92
Systematically investigating the impact of medication on the gut microbiome
Maier, L., & Typas, A. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.11.001 · Cited by 98
Singh, R., Bansal, Y., Medhi, B., & Kuhad, A. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.12.003 · Cited by 96
“Olanzapine-induced weight gain in germ-free mouse suggests a plausible role of gut microbiota in weight gain which is possible because of its antimicrobial potential to residential enteric bacteria (Morgan et al., 2014).”
BackgroundThe Microbiota–Gut–Brain Axis and Neurological Disorders: A Comprehensive Review
Nakhal, M. M., Yassin, L. K., Alyaqoubi, R., Saeed, S., Alderei, A., Alhammadi, A., Alshehhi, M., Almehairbi, A., Houqani, S. A., BaniYas, S., et al. (2024) · Life · doi:10.3390/life14101234 · Cited by 154
The gut microbiome influences the bioavailability of olanzapine in rats
Cussotto, S., Walsh, J., Golubeva, A. V., Zhdanov, A. V., Strain, C. R., Fouhy, F., Stanton, C., Dinan, T. G., Hyland, N. P., Clarke, G., et al. (2021) · eBioMedicine · doi:10.1016/j.ebiom.2021.103307 · Cited by 82
“Although the mechanistic basis for this association remains unclear, most attention has been placed on the antimicrobial effects of OLZ [9,10].”
BackgroundResultInfluentialRudzki, L., & Szulc, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00205 · Cited by 80
The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain
Kanji, S., Fonseka, T. M., Marshe, V. S., Sriretnakumar, V., Hahn, M. K., & Müller, D. J. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0820-z · Cited by 79
“71% increase in weight per 1% increase in abundance) suggesting that this class of bacterium could be mediating the OLZ-induced weight gain [50].”
BackgroundResultOlanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
Zhu, Z., Gu, Y., Zeng, C., Yang, M., Yu, H., Chen, H., Zhang, B., & Cai, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.897926 · Cited by 100
“In support, OLZ administration can increase the proportion of obesityrelated bacteria in the and cause weight gain, and the combination with prebiotics can alleviate this side effect (Morgan et al., 2014; Kao et al., 2018; Kao et al., 2019; Abbas et al., 2022).”
BackgroundTargeting the Microbiota in Pharmacology of Psychiatric Disorders
Pascale, A., Marchesi, N., Govoni, S., & Barbieri, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104856 · Cited by 67
Understanding the Effects of Antipsychotics on Appetite Control
Mukherjee, S., Skrede, S., Milbank, E., Andriantsitohaina, R., López, M., & Fernø, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.815456 · Cited by 84
“For example, mice treated with olanzapine have altered gut microbiota compositions associated with obesity (183).”
BackgroundApproach to the diagnosis and management of dysbiosis
Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1330903 · Cited by 91
The Role of the Gut-Brain Axis in Attention-Deficit/Hyperactivity Disorder
Dam, S. A., Mostert, J. C., Szopinska-Tokov, J. W., Bloemendaal, M., Amato, M., & Arias-Vasquez, A. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.05.001 · Cited by 64
Tomizawa, Y., Kurokawa, S., Ishii, D., Miyaho, K., Ishii, C., Sanada, K., Fukuda, S., Mimura, M., & Kishimoto, T. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa070 · Cited by 72
“Additionally, the side effects of antidepressants and antipsychotics, such as weight gain and extrapyramidal symptoms, are related to microbial composition in mice (Morgan et al., 2014; Munhoz et al., 2017).”
BackgroundThe Gut Microbiome in Schizophrenia and the Potential Benefits of Prebiotic and Probiotic Treatment
Liu, J. C. W., Gorbovskaya, I., Hahn, M., & Müller, D. J. (2021) · Nutrients · doi:10.3390/nu13041152 · Cited by 74
“They proposed olanzapine’s effect on AIWG to be through its in vitro antimicrobial activity against resident enteric bacteria [59].”
BackgroundSjöstedt, P., Enander, J., & Isung, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.682868 · Cited by 69
“A few pre-clinical studies that are cited have provided some preliminary evidence, supporting the involvement of the gut microbiome with psychopharmacological side effects (14), and even in the mechanism of action (15).”
BackgroundInfluentialPełka-Wysiecka, J., Kaczmarczyk, M., Bąba-Kubiś, A., Liśkiewicz, P., Wroński, M., Skonieczna-Żydecka, K., Marlicz, W., Misiak, B., Starzyńska, T., Kucharska-Mazur, J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101605 · Cited by 59
“[31] observed that weight gain depended on gut microbiota, and specific bacteria were responsible for weight gain.”
BackgroundInfluentialThirion, F., Speyer, H., Hansen, T. H., Nielsen, T., Fan, Y., Chatelier, E. L., Fromentin, S., Berland, M., Oñate, F. P., Pons, N., et al. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.01.009 · Cited by 67
“The link is plausible, because psychiatric and gut disorders are epidemiologically linked (4) and antipsychotic drugs have antibacterial properties (5).”
BackgroundThe Role of the Microbiome in Drug Response
Pryor, R. E., Martínez‐Martínez, D., Quintaneiro, L. M., & Cabreiro, F. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023612 · Cited by 59
Kamath, S., Stringer, A. M., Prestidge, C. A., & Joyce, P. M. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2233900 · Cited by 60
“Whilst oral delivery of olanzapine was not investigated by Kao et al., several studies such as one by Morgan et al. highlight the potential for olanzapine to contribute toward dysbiosis-driven weight gain [84].”
BackgroundLigezka, A. N., Sonmez, A. I., Corral-Frias, M. P., Golebiowski, R., Lynch, B., Croarkin, P. E., & Romanowicz, M. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110187 · Cited by 56
Systematic review of probiotics as an adjuvant treatment for psychiatric disorders
Forth, E., Buehner, B. J., Storer, A., Sgarbossa, C., Milev, R. V., & Meyyappan, A. C. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1111349 · Cited by 61
“Olanzapine has been found to shift the fecal microbiota in mice toward an “obesogenic” profile (Morgan et al., 2014), and all of the atypical antipsychotics used in the Dickerson et al.”
BackgroundOral-Intestinal Microbiota in Colorectal Cancer: Inflammation and Immunosuppression
Mo, S., Ru, H., Huang, M., Cheng, L., Mo, X., & Yan, L. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s344321 · Cited by 57
Flowers, S. A., & Ellingrod, V. L. (2015) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1640 · Cited by 52
Castellani, L. N., Costa-Dookhan, K. A., McIntyre, W. B., Wright, D. C., Flowers, S. A., Hahn, M., & Ward, K. M. (2019) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20190013 · Cited by 71
“Recent preclinical research in germ-free mice, or mice raised in a sterile environment, has also noted that the presence of a microbiome is essential for AP-induced weight gain [136,137].”
BackgroundThe gut microbiome in psychiatry: A primer for clinicians
Ameringen, M. V., Turna, J., Patterson, B. A., Pipe, A., Mao, R. Q., Anglin, R., & Surette, M. G. (2019) · Depression and Anxiety · doi:10.1002/da.22936 · Cited by 54
“The second‐generation atypical antipsychotic olanzapine has been shown to shift the microbial profile of mice to resemble that observed in obesity studies (Evans et al., 2017; Morgan et al., 2014).”
BackgroundThe Influence of Prebiotics on Neurobiology and Behavior
Kao, A. C.-C., Harty, S., & Burnet, P. W. J. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.08.007 · Cited by 58
The Gut Microbiome in Bipolar Disorder and Pharmacotherapy Management
Flowers, S. A., Ward, K. M., & Clark, C. T. (2020) · Neuropsychobiology · doi:10.1159/000504496 · Cited by 50
Huang, J., Kang, D., Zhang, F., Yang, Y., Liu, C., Xiao, J., Long, Y., Lang, B., Peng, X., Wang, W., et al. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac044 · Cited by 54
Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia
Zeng, C., Yang, P., Cao, T., Gu, Y., Li, N., Zhang, B., Xu, P., Liu, Y., Luo, Z., & Cai, H. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110097 · Cited by 55
Subramaniam, S., Elz, A., Wignall, A., Kamath, S., Ariaee, A., Hunter, A., Newblack, T., Wardill, H. R., Prestidge, C. A., & Joyce, P. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123614 · Cited by 45
The gut microbiome and antipsychotic treatment response
Seeman, M. V. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112886 · Cited by 47
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
Singh, R., Stogios, N., Smith, E., Lee, J., Maksyutynska, K., Au, E., Wright, D. C., Palma, G. D., Graff‐Guerrero, A., Gerretsen, P., et al. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221096525 · Cited by 44
Vasiliu, O. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1074736 · Cited by 42
“, Enterococcus faecalis, Escherichia coli) (64).”
BackgroundInfluentialThe Many Faces of Microbiota-Gut-Brain Axis in Autism Spectrum Disorder
Gonçalves, C. L., Doifode, T., Rezende, V. L., Costa, M. A., Rhoads, J. M., & Soutullo, C. A. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122357 · Cited by 42
Gut microbiota, metabolism and psychopathology: A critical review and novel perspectives
Groen, R. N., de Clercq, N. C., Nieuwdorp, M., Hoenders, H. J. R., & Groen, A. K. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1463507 · Cited by 40
Kraeuter, A.-K., Phillips, R., & Sarnyai, Z. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00799 · Cited by 46
Huang, J., Liu, C., Yang, Y., Kang, D., Xiao, J., Long, Y., Lang, B., Peng, X., Wang, W., Wang, X., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01958-2 · Cited by 40
Associations of the Gut Microbiome With Treatment Resistance in Schizophrenia
Vasileva, S. S., Yang, Y., Baker, A., Siskind, D. J., Gratten, J., & Eyles, D. W. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.5371 · Cited by 46
Polycystic Ovary Syndrome and Psychotic Disorder
Doretto, L., Mari, F. C., & Chaves, A. C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00543 · Cited by 52
Dopamine D2 receptor signaling modulates pancreatic beta cell circadian rhythms
Wei, H., Zapata, R. C., Valencia, M. L., Aslanoglou, D., Farino, Z. J., Benner, V., Osborn, O., Freyberg, Z., & McCarthy, M. J. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104551 · Cited by 40
“observation, mice were fed a high fat diet at the start of treatment with sulpiride, similar to previous mouse studies of APD induced weight gain (Lord et al., 2017; Morgan et al., 2014; Perez-Gomez et al., 2018).”
MethodBertelli, M. O., Azeem, M. W., Underwood, L., Scattoni, M. L., Persico, A. M., Ricciardello, A., Sappok, T., Bergmann, T. J., Keller, R., Bianco, A., et al. (2022) · Springer eBooks · doi:10.1007/978-3-319-95720-3_16 · Cited by 48
Li, L., Yoo, E.-S., Li, X., Wyler, S. C., Chen, X., Wan, R., Arnold, A. G., Birnbaum, S. G., Jia, L., Sohn, J., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202484 · Cited by 38
The Microbiota‐Gut‐Brain Connection: A New Horizon in Neurological and Neuropsychiatric Disorders
Faysal, M. F., Zehravi, M., Sutradhar, B., Amin, M. A., Shanmugarajan, T. S., Arjun, U. V. N. V., Ethiraj, S., Durairaj, A., Dayalan, G., Ahamad, S. K., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70593 · Cited by 49
“The study revealed that the weight gain induced by olanzapine in GF mice is influenced by the presence of gut microbiota, without causing significant weight gain [115].”
Pérez‐Gómez, A., Carretero, M., Weber, N., Peterka, V., To, A., Titova, V., Solis, G. M., Osborn, O., & Petrascheck, M. (2018) · Nature Communications · doi:10.1038/s41467-018-07684-y · Cited by 36
Sun, J., Zhao, F., Lin, B., Feng, J., Wu, X. F., Liu, Y., Zhao, L., Zhu, B., & Wei, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598170 · Cited by 40
Kao, A. C.-C., Chan, K. W., Anthony, D. C., Lennox, B. R., & Burnet, P. W. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.014 · Cited by 32
“A similar interpretation might be offered to reconcile altered Actinobacteria (Morgan et al., 2014), with no changes in Bifidobacteria spp. after olanzapine administration (Figure 7).”
Ben‐Azu, B., del Re, E. C., VanderZwaag, J., Carrier, M., Keshavan, M. S., Khakpour, M., & Tremblay, M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1139357 · Cited by 34
“Some preclinical and clinical experiments have also investigated the role of the gut microbiome in determining the adverse profile of antipsychotic medication (Davey et al., 2013; Morgan et al., 2014; Bahr et al., 2015).”
BackgroundInfluentialIUPHAR review: Microbiota-gut-brain axis and its role in neuropsychiatric disorders
Lee, S.-H., Han, C., & Shin, C. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107749 · Cited by 42
Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
Qian, L., He, X., Liu, Y., Gao, F., Lu, W., Fan, Y., Gao, Y., Wang, W., Zhu, F., Wang, Y., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00058-23 · Cited by 38
Luo, C., Wang, X., Huang, H., Mao, X., Zhou, H., & Liu, Z. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00371 · Cited by 31
Kamath, S., Hunter, A., Collins, K., Wignall, A. D., & Joyce, P. M. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16507 · Cited by 30
“1 ) was sufficient to potentiate weight gain (Morgan et al., 2014).”
Ferreira, V., Folgueira, C., Guillén, M., Zubiaur, P., Navares, M., Sarsenbayeva, A., López-Larrubia, P., Eriksson, J. W., Pereira, M. J., Abad‐Santos, F., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155335 · Cited by 32
Ling, Z., Lan, Z., Cheng, Y., Liu, X., Li, Z., Yu, Y., Wang, Y., Shao, L., Zhu, Z., Gao, J., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05533-9 · Cited by 29
“Studies showed that gut microbiota is essential for olanzapine-induced weight gain [74, 75].”
BackgroundMisera, A., Łoniewski, I., Palma, J., Kulaszyńska, M., Czarnecka, W., Kaczmarczyk, M., Liśkiewicz, P., Samochowiec, J., & Skonieczna‐Żydecka, K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1125022 · Cited by 30
Metabolic effects of atypical antipsychotics: Molecular targets
Fonseca, M., Carmo, F., & Martel, F. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13347 · Cited by 28
“121 The involvement of the gut microbiota in the metabolic effects of AAPs was also observed in humans.”
BackgroundHuang, D., Gao, J., Li, C., Nong, C., Huang, W., Zheng, X., Li, S., & Peng, Y. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05878-9 · Cited by 29
Dharmaratne, P., Rahman, N., Leung, A., & Ip, M. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1927170 · Cited by 29
“Importantly, antipsychotic drugs such as olanzapine [15], pimozide [16], fluphenazine [17], and flupenthixol dihydrochloride [18] were proven to pose in vitro antibacterial properties against a broad spectrum of bacteria alone and in combination with other antibiotics.”
Background
Metadata
- Authors
- Morgan, A. P., Crowley, J. J., Nonneman, R. J., Quackenbush, C. R., Miller, C. N., Ryan, A. K., Bogue, M. A., Paredes, S. H., Yourstone, S., Carroll, I. M., Kawula, T. H., Bower, M. A., Sartor, R. B., & Sullivan, P. F.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Jackson Laboratory (US)
- Corresponding author
- Sullivan, Patrick F.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-15
- Volume
- 9
- Issue
- 12
- Pages
- e115225
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4266663
- OpenAlex
- W2072944905
- Cited by
- 197
- References
- 61
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 19 · 2023: 25 · 2022: 21 · 2021: 17 · 2020: 22 · 2019: 23 · 2018: 16 · 2017: 9 · 2016: 7 · 2015: 6
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- UNC Libraries
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (P40OD010995)
- National Institute of Mental Health (R21MH097173, K01MH094406, F30MH103925)
- National Institute of General Medical Sciences (T32GM008719, T32GM067553)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034987, P30DK056350)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- olanzapine, gut microbiota, weight gain, antipsychotic adverse effects, germ-free mice, antimicrobial activity, atypical antipsychotics, drug-microbiome interactions
- MeSH terms
- Gastrointestinal Microbiome, Olanzapine, Animals, Benzodiazepines, Female, Antipsychotic Agents, Weight Gain, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.